There are four coronavirus vaccines in late-stage studies — here’s how they differ | WHAT REALLY HAPPENED

There are four coronavirus vaccines in late-stage studies — here’s how they differ

Johnson & Johnson’s investigational COVID-19 vaccine entered Phase 3 clinical trials this week, making it the fourth vaccine candidate in the U.S. to do so and providing additional details that can help investors differentiate the pool of late-stage coronavirus vaccines.

Shares of J&J JNJ, +0.68% were up 0.3% in trading on Friday, two days after the health care giant announced it had dosed the first of an estimated 60,000 participants in the Phase 3 trial for Ad26.COV2.S, which is also referred to as JNJ-78436735.

Comments

Conflict of interest?

Ethan Allen and...

Trump own shares in big pharma companies including Pfizer, Merck, Celgene and GlaxoSmithKline; retailer Walmart, and consumer goods firms Procter & Gamble and Johnson & Johnson. He also hold stakes in a variety of multinational oil companies like Shell, Chevron and Exxon Mobil. https://www.forbes.com/sites/jenniferwang/2016/11/29/trumps-stock-port...

Comment viewing options

Select your preferred way to display the comments and click "Save settings" to activate your changes.

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA